Fate Therapeutics ($FATE) Insider Trading & Smart Money Activity
Fate Therapeutics, Inc. ($FATE) has 9 insider trades and 2 13F position changes on file. Insiders filed 9 Form 4 transactions in the last 12 months, none of them open-market purchases or sales.
- Insider buyers (12 mo)
- 0
- Insider sellers (12 mo)
- 0
- Net insider $ (12 mo)
- $0
- Congress trades (12 mo)
- 0
- 13F moves on file
- 2
- Analyst ratings on file
- 0
FATE insider buying and selling by quarter
| Quarter | Insider buys | Insider sales | Congress buys / sales | 13F added / cut |
|---|---|---|---|---|
| Q1 2026 | 0 | 0 | 0 / 0 | 0 / 0 |
| Q2 2026 | 0 | 0 | 0 / 0 | 0 / 0 |
| Q3 2026 | 0 | 0 | 0 / 0 | 0 / 0 |
| Q4 2026 | 0 | 0 | 0 / 0 | 0 / 0 |
Insider buys and sales count open-market trades only (Form 4 codes P and S). Grants, option exercises and tax withholding are left out.
All FATE insider, congress, 13F and analyst activity
| Date | Source | Who | Action | Shares | Value / amount | ΔOwn | 1W | 1M | 6M | Filing | Story |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Insider | Yuan Xu | Buy (Grant or award) | 87.90K sh | +4.4% | +46.6% | — | |||||
| Insider | LLC Redmile Group | Buy (Grant or award) | 87.90K sh | +4.4% | +46.6% | Read | |||||
| Insider | William Rastetter | Buy (Grant or award) | 87.90K sh | +4.4% | +46.6% | — | |||||
| Insider | Lee Michael Stewart | Buy (Grant or award) | 87.90K sh | +4.4% | +46.6% | — | |||||
| Insider | Karin Jooss | Buy (Grant or award) | 87.90K sh | +4.4% | +46.6% | — | |||||
| Insider | Laura Hamill | Buy (Grant or award) | 175.80K sh | +4.4% | +46.6% | — | |||||
| Insider | Robert Epstein | Buy (Grant or award) | 87.90K sh | +4.4% | +46.6% | — | |||||
| Insider | Shefali Agarwal | Buy (Grant or award) | 87.90K sh | +4.4% | +46.6% | — | |||||
| Insider | Matt Abernethy | Buy (Grant or award) | 87.90K sh | +4.4% | +46.6% | — | |||||
| 13F | Baker Bros. Advisors | Sold out | -2.49M sh | — | |||||||
| 13F | Baker Bros. Advisors | Sold out | -2.49M sh | — |
1W / 1M / 6M = how FATE moved from the trade or filing date.
Insider trading in FATE: who is buying and selling
| Insider | Role | Trades | Open-market net | Shares held | Last trade |
|---|---|---|---|---|---|
| Yuan Xu | 1 | — | Jun 12, 2026 | ||
| LLC Redmile Group | 1 | — | Jun 12, 2026 | ||
| William Rastetter | 1 | — | Jun 12, 2026 | ||
| Lee Michael Stewart | 1 | — | Jun 12, 2026 | ||
| Karin Jooss | 1 | — | Jun 12, 2026 | ||
| Laura Hamill | 1 | — | Jun 12, 2026 | ||
| Robert Epstein | 1 | — | Jun 12, 2026 | ||
| Shefali Agarwal | 1 | — | Jun 12, 2026 | ||
| Matt Abernethy | 1 | — | Jun 12, 2026 |
Institutions moving FATE (13F)
Frequently asked questions
What is the latest insider trade in FATE?
Yuan Xu filed a buy (grant or award) of 87.90K sh on Jun 12, 2026.
Which institutions changed their FATE positions?
Recent 13F filers moving the stock include Baker Bros. Advisors.
Other biotechnology stocks
Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.
Get a text when insiders, Congress or big funds trade a stock.
Free. Reply STOP anytime.